BackCidara Therapeutics Overview

Cidara Therapeutics EBIT

EBIT (Earnings Before Interest and Taxes) analysis for CDTX.

Quarterly EBIT

-$88.63M
↓ 409.53% YoY

As of Sep 30, 2025

Annual EBIT (TTM)

-$195.49M
↓ 331.39% YoY

Trailing 12 months ending Sep 30, 2025

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin